Tragic Link Between Approved Weight-Loss Drug and Nurse’s Death Raises Safety Concerns
The recent death of 58-year-old nurse Susan McGowan in the UK has been connected to the weight-loss drug tirzepatide, marketed as Mounjaro. After two low-dose injections, she experienced severe abdominal issues that led to multiple organ failure, with the drug noted as a contributing factor. Despite its recent NHS approval, McGowan’s case has raised alarms about the safety of GLP-1 receptor agonists, a class of drugs designed to assist with weight loss. Health officials emphasize ongoing monitoring and safety assessments as they continue to weigh benefits against risks.